|
HS Code |
868906 |
| Generic Name | Candesartan |
| Brand Name | Atacand |
| Drug Class | Angiotensin II Receptor Blocker (ARB) |
| Route Of Administration | Oral |
| Indications | Hypertension, Heart Failure |
| Dosage Forms | Tablet |
| Mechanism Of Action | Blocks angiotensin II type 1 receptors |
| Pregnancy Category | D |
| Common Side Effects | Dizziness, headache, hyperkalemia |
| Half Life | 9 hours |
| Protein Binding | 99% |
| Metabolism | Hepatic (CYP2C9) |
| Excretion | Urine and feces |
| Contraindications | Pregnancy, hypersensitivity to candesartan |
| Atc Code | C09CA06 |
As an accredited Candesartan factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Candesartan packaging features a white and blue box, labeled "Candesartan 16 mg," containing 30 film-coated tablets in blister strips. |
| Shipping | Candesartan is shipped in accordance with pharmaceutical and chemical transport regulations. It is securely packaged in leak-proof, clearly labeled containers, often within secondary protective packaging. The shipment is maintained at controlled room temperature, protected from moisture and light, with accompanying documentation, including safety data sheets, as required for safe handling and regulatory compliance. |
| Storage | Candesartan should be stored at room temperature, typically between 20°C and 25°C (68°F and 77°F). The medication must be kept in a tightly closed container, away from moisture, heat, and direct light. It should be kept out of reach of children and not stored in the bathroom to avoid excess humidity. Always follow manufacturer and pharmacist storage instructions. |
|
Purity 99%: Candesartan with a purity of 99% is used in pharmaceutical formulations, where it ensures consistent antihypertensive efficacy. Molecular weight 440.45 g/mol: Candesartan with a molecular weight of 440.45 g/mol is used in oral tablet production, where it enables accurate dosage calculation. Melting point 168°C: Candesartan with a melting point of 168°C is used in solid dispersion systems, where it enhances thermal stability during processing. Particle size <10 µm: Candesartan with a particle size less than 10 µm is used in direct compression tablets, where it improves bioavailability through increased surface area. Stability at 25°C: Candesartan with stability at 25°C is used in ambient storage medicines, where it maintains chemical integrity over shelf life. Solubility 0.045 mg/mL: Candesartan with a solubility of 0.045 mg/mL is used in suspension formulations, where it controls drug release rate for sustained action. pH stability range 2–8: Candesartan with a pH stability range of 2–8 is used in gastrointestinal drug delivery, where it resists degradation in variable pH environments. HPLC assay ≥98%: Candesartan with an HPLC assay of ≥98% is used in regulatory compliant manufacturing, where it guarantees batch-to-batch consistency. |
Competitive Candesartan prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Blood pressure medication often sparks a mental picture of pill boxes and routine checkups, but picking the right one isn’t as straightforward as it might seem. Candesartan stands as one of those options with a solid reputation among doctors who specialize in treating high blood pressure and heart failure. As someone who's cared for a parent with hypertension for years, I’ve watched the anxiety people feel when starting a new medication. Candesartan’s entry into the daily routines of many patients not only brings the hope of more stable readings but also introduces a few key simplifications.
Candesartan belongs to a class of drugs called angiotensin II receptor blockers. These medicines target a hormone that tends to constrict blood vessels and drive blood pressure up. By blocking the effect of this hormone, Candesartan helps vessels relax, making it easier for the heart to pump blood and lowering the risk of strokes and heart attacks. My own experience with angiotensin receptor blockers in a family context made me notice a calmer, more gradual improvement in my loved one's blood pressure, compared to the steep swings that sometimes came with older prescriptions like beta-blockers.
Doctors tend to prescribe Candesartan in tablet form. Dosages are usually either 4 mg, 8 mg, 16 mg, or 32 mg per day, depending on the patient’s needs and medical history. The ability to start with a low dose and work up to higher strengths offers flexibility, making it easier to adjust therapy without switching to a completely different drug. Unlike some other drugs for high blood pressure, Candesartan is usually taken once a day, which I found was far less disruptive and easier for most people to keep on track.
I’ve had neighbors share that side effects like dry cough and dizziness cut their previous medications short. Candesartan, by targeting a different system in the body compared to ACE inhibitors, largely avoids the nagging cough those drugs can trigger. That difference might sound minor, but when you’re trying to stick with a regimen over a span of years, even small benefits can decide whether someone actually keeps up with their pills.
The difference between Candesartan and older blood pressure drugs shows up most for those already juggling multiple prescriptions. Some medications, such as diuretics or beta-blockers, may sap energy or cause more frequent trips to the bathroom. While every drug has its own list of warnings, Candesartan tends to have a gentler effect on daily life. In my own circle, several people with busy work schedules felt relieved to ditch midday pills and side effects like fatigue. Medical research supports this: studies involving patients with both hypertension and heart failure show that Candesartan reduces hospitalizations for heart failure and may help people live longer, particularly when used alongside other established therapies.
It’s tempting to think all drugs designed to control blood pressure do pretty much the same thing, but the details make the difference. Most health issues linked to uncontrolled blood pressure—strokes, kidney disease, heart attacks—develop over many years. Picking a medicine that people will actually use every day is often the single most important factor in staying healthy. Candesartan’s once-daily dosing and generally mild side effects mean those odds are better. As a caregiver, watching how someone’s confidence returns after switching to a regimen that doesn’t derail their daily routine makes a strong impression.
Candesartan, like other angiotensin receptor blockers, has also been studied for its impact in protecting the kidneys, especially in folks with diabetes. In clinical research, people with diabetes and protein in their urine—a signal that the kidneys are under strain—often saw a slowdown in further kidney damage compared to those taking some other types of blood pressure medicine. The difference wasn’t just a number in a chart; it meant delaying kidney failure and the move to dialysis. Having lived with relatives worried about their advancing kidney problems, I know how much of a lifeline an extra two or three years can mean.
There’s another factor too: cost. Generic Candesartan has become widely available in many countries. As a result, more people can access regular treatment, and they’re not forced to make tough choices at the pharmacy counter between blood pressure control and other necessary expenses. Affordability expands the pool of people who benefit, and as doctors and health systems keep looking for value, drugs like this become the backbone of a sustainable care model.
Doctors weighed Candesartan not just against the possibility of doing nothing, but also against the whole shelf of other available drugs. ACE inhibitors, calcium channel blockers, diuretics—each have their own role, strengths, and weaknesses. If you look at ACE inhibitors, they can cause a persistent dry cough in about 10-20 percent of people. Beta-blockers work, but some patients struggle with fatigue, cold hands, or mood changes. Diuretics, for their part, may tip people towards low potassium. In real-world clinics, the doctor’s main hope is to find a treatment people find tolerable enough to stick with for the long haul.
Candesartan rarely causes cough, and compared to older ARBs, delivers strong, consistent blood pressure control. Studies from the early 2000s suggested that Candesartan binds more tightly and for longer to the angiotensin II receptor than some similar drugs, like Losartan. That seems like a small chemical detail, but it can mean stronger or more consistent effects across a full 24 hours with a single daily dose. A friend of mine, who tried both Losartan and Candesartan, described how her numbers stayed steadier on Candesartan, with less variability between morning and evening readings.
Some blood pressure drugs get metabolized differently among people with different backgrounds or diets, but Candesartan’s breakdown in the body happens in a predictable way. This makes it easier for doctors to adjust doses and minimize unpleasant surprises. In people with liver or kidney problems, doctors are careful and may lower the dose, but the medicine itself remains a go-to for many patients who don’t find relief with other drugs or who had to quit due to side effects.
Hypertension often shows up hand-in-hand with other issues like diabetes, high cholesterol, or early heart failure. Combo pills containing both Candesartan and a diuretic, such as hydrochlorothiazide, have appeared on the market, aiming to make life simpler for people who need several types of treatment at the same time. Having fewer pills to swallow means less chance of forgetting a dose, and less frustration from feeling “over-medicated.”
No medicine works equally well for everyone, and Candesartan is no exception. Though side effects remain less common compared to many drugs in its category, some people report headaches, mild dizziness, or a sense of fatigue, especially after the first dose or two. Lab checks help spot rare risks like too much potassium in the blood or drops in kidney function, both of which can show up in a small slice of patients. It was hard at first for my family member to see the need for regular blood tests, but after a few routines, it became simple and kept her on track without surprises.
Older adults, who usually take several medications at once, often worry about drug interactions and sudden blood pressure drops. Candesartan, thanks to its gradual onset and targeted mode of action, usually slips into the mix more smoothly than some fast-acting blood pressure drugs. Doctors recommend monitoring, especially at the start, just to make sure no unexpected issues pop up.
Pregnant women or those planning a pregnancy should avoid Candesartan. Like other ARBs, this medication can harm developing babies. For women of reproductive age, these conversations happen early and often between them and their healthcare teams. Such planning helps sidestep severe risks to newborns and lays the groundwork for finding safe, effective alternatives during pregnancy.
People sometimes ask about the so-called “black box warning,” which signals special safety steps for a drug. In the case of Candesartan, this focuses squarely on pregnancy risks and the need for regular kidney and electrolyte monitoring, especially for those with diabetes, older age, or existing kidney problems. Keeping these details in mind improves the odds of success with the fewest headaches along the way.
Stories from doctor offices, family kitchens, and online support groups bring the measurement charts to life. I remember an elderly neighbor who complained for years of troublesome cough and nighttime disturbances, only to find more restful nights after switching to Candesartan. While every story is unique and some people still switched again for personal tolerance, this type of relief mattered in daily life.
A primary care doctor who attended a support group I facilitated once described Candesartan as “steady and dependable,” especially for older patients with a history of irregular heart rhythms or unpredictable blood pressure swings. He explained that in his clinic, patient adherence improved noticeably after switching some to once-daily ARBs like Candesartan.
Online forums sometimes highlight folks worried about cost or access to generics, but those sources also show broad satisfaction when people find a medicine that works for them with minimal day-to-day disruption. High blood pressure rarely feels urgent in the moment but can erode quality of life over years. Giving people a way to tame those risks without constant visits to the doctor’s office, or exhausting daily routines, improves confidence all around.
Much of the progress in blood pressure care doesn’t come down to any one breakthrough, but a series of steps that each chip away at persistent health problems. Making medicines like Candesartan more widely available—and working to educate both patients and providers about their different roles—raises the standard for what blood pressure care can look like. As more data emerges about long-term outcomes, such as reducing hospital admissions or sparing people the ordeal of heart failure, the story of Candesartan continues to grow.
Changes in medication guidelines, access to insurance, and the ever-evolving list of generic suppliers may shuffle which drugs see the most use from year to year, but the underlying need stays the same. Doctors keep their eyes peeled for the right balance between cost, availability, tolerability, and real-world results. So far, Candesartan holds a reliable spot on that roster for millions worldwide who rely on stable blood pressure control.
Looking ahead, there’s plenty of room to improve how people get diagnosed and matched with the right blood pressure medicines. The hope is that more robust education for patients—in plain language, not pharmaceutical jargon—along with easier-to-access clinics and virtual health visits, will make sticking with treatment plans simpler for everyone, from busy parents to retirees. Efforts to check in more often with patients, not just with lab results but with practical checklists and personal goals, already make a difference in my own experience supporting loved ones.
When someone gets a prescription for Candesartan, it’s hardly ever the end of the story. Ongoing conversations with pharmacists, routine checks of blood work, and honest assessments of how life is going outside the doctor’s office round out what success looks like. The process isn’t perfect—and no drug solves every problem—but finding an option that encourages daily commitment sets the stage for better outcomes in the long run.
In clinic visits and family discussions, the question comes up again and again: what’s the right fit for this person, not just the average case? Candesartan stands out for people who want their treatment to blend into daily routines and for those who tried other medicines and had to stop due to side effects. Doctors trust it for its lasting power, once-daily dosing, and its performance over years, not just a few good months.
The landscape for blood pressure treatments keeps shifting, and patients remain on the front lines of these changes. Having medications like Candesartan, backed by years of data and millions of real-world experiences, offers hope that high blood pressure won’t be the silent threat it was for our grandparents. Instead, it becomes one more manageable piece of a long, healthy life—an improvement hard to measure by numbers alone, but impossible to miss in everyday living.